Inve US ▾
NONOC

Northrop Grumman (NOC) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Industrials· Apr 21, 2026

Source: earnings call transcript

Executive summary

Northrop Grumman Q1 FY26 — Strong Sales Growth and Accelerated Production on Key Programs

Northrop Grumman delivered a strong first quarter, marked by robust organic sales growth and solid operating performance across most segments. Strategic investments in capacity and accelerated production agreements for critical programs like B-21 and Sentinel underscore confidence in future growth. While the Space segment faced specific program headwinds, the company maintains its full-year outlook amidst a high-demand geopolitical environment.

Highlights

5
  • Organic sales increased 5% year-over-year, consistent with full-year expectations.

  • Segment operating income exceeded $1 billion, with segment margins improving to 10.8%.

  • Aeronautic Systems sales grew 17%, driven by B-21 and restricted programs, with operating margins improving to 9.3%.

  • Defense Systems organic sales increased 10%, fueled by Sentinel and tactical solid rocket motors, achieving 9.7% operating margins.

  • Mission Systems operating income rose 20%, leading to a 15.1% operating margin, driven by favorable earnings adjustments.

Concerns

4
  • Space segment sales and operating income were down year-over-year, impacted by a $98 million headwind from the NGI contract closeout in Q1 FY25.

  • The Space segment also recognized a $71 million unfavorable earnings adjustment on the GEM 63XL program.

  • Aeronautic Systems experienced lower volume on the F/A-18 program, partially offsetting overall segment growth.

  • Mission Systems saw lower volume on Sabre and electronic warfare programs.

Guidance & targets

CategoryTargetConfidence
Full-year sales
$43.5 billion and $44 billion
high materiality
High
Full-year segment operating income margin rate
low to mid-11%
high materiality
High
Full-year free cash flow
$3.1 billion to $3.5 billion
high materiality
High
Full-year capital expenditures
$1.85 billion
medium materiality
High
Q2 sales growth
high single-digit sequential sales growth
medium materiality
High
B-21 capital expenditures
$200 million
medium materiality
High
Sentinel Milestone B decision
later this year
high materiality
High
Sentinel first flight
2027
high materiality
High
Sentinel initial operating capability (IOC)
early 2030s
high materiality
High
B-21 arrival at Ellsworth Air Force Base
2027
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Aeronautic Systems (AS)
Strong growth driven by key strategic programs, with margin improvement reflecting better program performance.
Sales driven by higher sales on B-21 and other restricted programsTACAMO sales higher as program rampsSales increases partially offset by lower volume on F/A-18Operating margins improved due to absence of B-21 loss provision booked in Q1 2025
—17%—9.3%
Defense Systems (DS)
Solid performance with strong organic growth from critical defense programs and munitions.
Organic sales increased 10% year-over-yearDriven by higher volume on Sentinel as program rampsSales also higher due to increased volume on tactical solid rocket motors and Integrated Battle Command programs
—5%—9.7%
Mission Systems (MS)
Modest sales growth, but significant operating income and margin improvement driven by favorable adjustments.
Driven by increased volume on restricted airborne radar and marine programsIncreases partially offset by lower volume on Sabre and electronic warfare programsOperating income increased 20% due to a higher level of net favorable earnings adjustments
—2%—15.1%
Space
Sales and operating income declined due to specific program headwinds, despite strong performance in other areas of the portfolio.
NGI program recognized $98 million in Q1 FY25 sales as part of contract closeout, creating a year-over-year headwind in Q1 FY26Recognized an unfavorable earnings adjustment of $71 million on the GEM 63XL program, lowering sales and operating incomePerformance elsewhere in the space portfolio was strong with growth on FDA programs and restricted space
down——down

NOC operating KPIs by quarter

NOC operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2024 Q4 FY24 Mar 2025 Q1 FY25 Jun 2025 Q2 FY25 Sep 2025 Q3 FY25 Dec 2025 Q4 FY25This call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
Backlog
~$91.5B We ended the year with a backlog of approximately $91.5 billion and a book-to-bill ratio at 1.23x, providing a solid foundation for future growth. Source: earnings call transcript
$92.8B Within this environment, we continue to see strong demand signals from our global customers, resulting in another record backlog in the first quarter of $92.8 billion, and that's inclusive of strong international bookings. Source: earnings call transcript
——
$95B+ We ended the year with over $95 billion in backlog, a new company record, driven by over $46 billion in net awards in 2025. Source: earnings call transcript
$96M Awards totaled $9.8 billion in Q1, and we ended the period with $96 million in backlog. Source: earnings call transcript
$105B Backlog continues to grow, including a new record high of $105 billion. Source: earnings call transcript
+109275%
Orders
$17.3B Reflecting this demand, we booked $17.3 billion in new awards in the fourth quarter and approximately $51 billion for the full year. Source: earnings call transcript
————
$9.8B Awards totaled $9.8 billion in Q1, and we ended the period with $96 million in backlog. Source: earnings call transcript
$20B We delivered $20 billion in net awards in the quarter, driving a book-to-bill ratio of 1.84x. Source: earnings call transcript
+104.1%
Book-to-bill ratio International—
1.45 ratio As a result, we continue to see opportunities to increase our international sales over the coming years, and we are making steady progress in this area, with a first quarter international book-to-bill of 1.45x and international sales up 11% in the quarter. Source: earnings call transcript
1.4 ratio And we had seen that reflected in very strong book-to-bill, 1.4x in international. Source: earnings call transcript
————-3.4%
Book-to-bill ratio ———
1.17 ratio In fact, we achieved an exceptionally strong book-to-bill of 1.17x in the quarter. Source: earnings call transcript
——
1.84 ratio We delivered $20 billion in net awards in the quarter, driving a book-to-bill ratio of 1.84x. Source: earnings call transcript
—

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Orderbook & backlog

Q1 Awards $9.8 billion Q1 FY26
Total Backlog $96 billion Q1 FY26

Product announcements

ProductTypeDetails
Glide Phase Interceptor (GPI)launch
B-21 Production Rateupdate
Sentinel Launch Silo Tubemilestone
Artemis II Solid Rocket Motorsmilestone

Deals & partnerships

Air Force Agreement to increase B-21 production rate

Finalized an agreement to increase the annual production rate of the B-21 by 25%. Supported by customer funding and company-funded investment.

US Department of Defense (implied) Award for Glide Phase Interceptor (GPI) development $1.3 billion

Secured an award to accelerate development of the Glide Phase Interceptor, designed to intercept hypersonic missiles.

Hungarian company Relationship for space-related work

Announced a relationship with a Hungarian company and are pursuing work there, contributing to the growing international pipeline for Space Systems.

Capital programs

SRM and Munition Technologies Investment underway $2 billion
Start: past several years

Benefit:modernizing facilities, establishing strong U.S. manufacturing base with capacity

Proactive investment to position the company for the growing market for solid rocket motors and munitions.

B-21 Production Capacity Expansion underway $2.5 billion
Period spend: $200 million
Funding: company-funded investment
Start: FY26

Benefit:increased annual production rate of the B-21 by 25%

Investment primarily for new facilities, phased over multiple years, with the majority in the '27, '28, '29 timeframe. Supported by customer funding.

New Facilities and Manufacturing Space Expansion completed
Start: last 2 years

Benefit:over 20 new facilities, more than 2 million square feet of manufacturing space

Investments made to build capability and capacity to provide solutions at scale for customers.

Risks & headwinds

Space Segment Performance Q1 FY26

$98 million headwind from NGI contract closeout in Q1 FY25; $71 million unfavorable earnings adjustment on GEM 63XL program in Q1 FY26.

Mitigation:Strong performance elsewhere in the space portfolio with growth on FDA programs and restricted space.

Lower Volume on F/A-18 Q1 FY26

Partially offset sales increases in Aeronautic Systems.

Lower Volume on Sabre and Electronic Warfare Programs Q1 FY26

Partially offset sales increases in Mission Systems.

Supply Chain Bottlenecks

Suppliers need to scale with Northrop Grumman.

Mitigation:Company is identifying bottlenecks, helping suppliers resource their own scaling, and working to have needed capacity from them.

F-35 Radar Concurrent Development and Production

Known risk.

Mitigation:Working in coordination with the JPO to complete development and quickly ramp production; opened a new facility for accelerating production.

Q&A highlights

Can you provide details on the B-21 CapEx timeline, how production flows, and if there are protections against a B-2 curtailment scenario?

Kathy Warden stated that approximately $200 million in CapEx is expected this year for B-21, with the majority of the $2.5 billion company-funded investment occurring in the 2027-2029 timeframe. She clarified that the revenue profile will follow facility completion and that the contract has a committed quantity, with strong support for Triad modernization, distinguishing it from the B-2 program.

“So we expect $200 million or so of CapEx this year, and that's why we reflected that increase in our CapEx guidance for 2026. As we've said before, we do expect the majority of the capital expenditure to happen in the '27, '28, '29 timeframe and largely be completed this decade.”

asked by Robert Stallard · answered by Kathy Warden

3 min read 8 chapters

Detailed narrative

Strategic Investments & Capacity Expansion

Northrop Grumman has proactively invested in its business, opening over 20 new facilities and adding more than 2 million square feet of manufacturing space across the U.S. in the last two years. This effort aims to build capability and capacity, providing solutions at the scale customers need.

The company has invested over $2 billion in solid rocket motor (SRM) and munition technologies over the past several years, establishing a strong U.S. manufacturing base.

Geopolitical Environment & Defense Spending

The company notes a fundamental shift in the geopolitical environment, with global military spending rising approximately 40% over the past decade and expected to continue. The U.S. appropriated $1 trillion for defense in FY26, and the administration submitted a $1.5 trillion defense budget request for FY27, representing a 44% increase over current funding levels and 5% of GDP.

This sustained support for key programs like B-21 and Sentinel is encouraged by strong bipartisan backing.

Solid Rocket Motors & Munitions Growth

The Defense Systems business is fueled by growing demand for SRMs, smart munitions, and tactical missiles. The weapons business is nearing 10% of total company sales and is positioned to grow well above the company average. Tactical SRM production capacity has already doubled, with further expansion expected by 2027, providing modular and adaptable production lines to meet demand.

Triad Modernization: Sentinel Program Acceleration

The Sentinel program is making significant progress, advancing missile development, command and control systems, and maturing design. The program delivered double-digit growth in Q1. In March, a prototype of the Sentinel launch silo tube was broken ground to validate structural design. Milestone B decision is expected later this year, with first flight in 2027 and initial operating capability in the early 2030s.

Triad Modernization: B-21 Production Ramp-Up

The B-21 program is moving through testing aggressively, including aerial refueling trials. The company is on track for testing and production to arrive at Ellsworth Air Force Base in 2027. A Lot 4 LRIP award was received in Q1, following Lot 3 in Q4 last year.

An agreement with the Air Force will increase the annual production rate by 25%, supported by customer funding and approximately $2.5 billion in company-funded investment.

Missile Defense & Hypersonic Interceptors

Widespread adoption of ballistic missiles and drones reinforces the urgent need for air and missile defense capabilities, which now account for nearly 10% of company sales. Shortly after the quarter, Northrop Grumman secured a $1.3 billion award to accelerate development of the Glide Phase Interceptor (GPI), designed to intercept hypersonic missiles, a critical capability given their proliferation.

International Opportunities & Export Acceleration

The company sees opportunities to accelerate international sales, particularly in the Middle East, due to heightened urgency. While international cycles are typically longer, Northrop Grumman is working with the Department of Defense to accelerate export approvals and aggregate demand. The Space Systems segment, while currently having the least international pipeline, is seeing growth and is expected to be a key contributor in the future.

F-35 Radar Production Update

Northrop Grumman is building an advanced radar for the F-35, engaging in concurrent development and production, a known risk to expedite capability delivery. The Joint Program Office (JPO) plans to accelerate production capacity, and Northrop Grumman has opened a new facility to support this ramp-up. The company is working to complete development and quickly ramp production to deliver this game-changing radar.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.